腎と骨代謝 Vol.30 No.4(7)


特集名 副甲状腺─病態解明と治療法の進歩
題名 CKD患者における二次性副甲状腺機能亢進症の発症機序
発刊年月 2017年 10月
著者 濱野 高行 大阪大学大学院医学系研究科腎疾患統合医療学
【 要旨 】 PTHを上げる古典的因子は三つに大別される.一つ目はP負荷あるいは高P血症,二つ目の因子は低Ca血症あるいはCa摂取不足,三つ目は低25(OH)Dまたは低1,25(OH)2D血症である.保存期では,たとえば間質性腎炎において低1,25(OH)2D血症とそれに伴う低Ca血症によりPTHは高いことが多い.これらの古典的MBD因子以外の因子にも最近注目が集まっている.肥満やアルドステロン系の亢進や心不全は重要なリスク因子であり,二次性副甲状腺機能亢進症の病態に拍車がかかっている可能性がある.長期透析患者ではおもにMBD因子が長期に影響した結果,副甲状腺の自律的増殖が完成し,結節性副甲状腺腫大になると,これらの因子を補正するだけでは改善しない.また腎移植後は,びまん性過形成は改善しても結節性の部分は残存し,遷延性副甲状腺機能亢進症となる.
Theme Progress in parathyroid research : Pathophysiology and treatment
Title The mechanism for the development of secondary hyperparathyroidism in chronic kidney disease (CKD)
Author Takayuki Hamano Department of Comprehensive Kidney Disease (CKDR), Osaka University Graduate School of Medicine
[ Summary ] The classical factors contributing to the development of secondary hyperparathyroidism (II HPT) are (i) hyperphosphatemia or phosphate loading,(ii) hypocalcemia or calcium deficiency, and (iii) low serum levels of 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D. In pre-dialysis patients, for example, II HPT is usually severe in patients with interstitial nephritis, due to low serum calcitriol levels and resultant hypocalcemia. Much attention is now being paid to factors contributing to II HPT other than mineral disturbances, such as the stimulated renin angiotensin aldosterone system, congestive heart failure, and obesity, where high PTH levels, per se, may lead to their pathophysiolog. In dialysis patients of long duration, longterm mineral disturbance promotes the proliferation of parathyroid chief cells, resulting in nodular hyperplasia, which is resistant to active vitamin D therapy and to the optimal control of serum mineral levels. Diffuse hyperplasia regresses after successful renal transplantation but this is not the case in nodular hyperplasia, which is associated with persistent hyperparathyroidism in renal transplant recipients.
戻る